XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.1
BUSINESS SEGMENT INFORMATION (Tables)
 3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Summary of Segment Reporting Information by Segment The following table is a summary of segment information for the three months ended March 31, 2021 and 2020. Segment asset information is not presented since it is not used by the CODM at the operating segment level. Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment. General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses. The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company’s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.
Three Months Ended March 31,
20212020
Net revenues:  
DIS business$2,643 $1,744 
All other operating segments77 78 
Total net revenues $2,720 $1,822 
Operating earnings (loss):  
DIS business$712 $205 
All other operating segments9 9 
General corporate activities(61)(39)
Total operating income660 175 
Non-operating expense, net(34)(57)
Income before income taxes and equity in earnings of equity method investees626 118 
Income tax expense(153)(26)
Equity in earnings of equity method investees, net of taxes17 14 
Net income490 106 
Less: Net income attributable to noncontrolling interests21 7 
Net income attributable to Quest Diagnostics$469 $99 
Schedule of Revenues by Major Service Net revenues by major service were as follows:
Three Months Ended March 31,
20212020
Routine clinical testing services$1,032 $945 
COVID-19 testing services828 24 
Gene-based and esoteric (including advanced diagnostics) testing services653 641 
Anatomic pathology testing services130 134 
All other77 78 
Total net revenues$2,720 $1,822